Hari Anant Deshpande, MD

Associate Professor of Medicine (Medical Oncology)

Clinical Interests

  • Medical Oncology
  • Sarcoma

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Endocrine Oncology Program | Head and Neck Cancer Surgery Program | Prostate and Urologic Cancers Program

General Urology

Medical Oncology: Subset Medical Oncology Faculty

Medical Oncology

Yale Medical Group

Board Certifications

  • Hematology (Internal Medicine) AB of Internal Medicine (1998)

  • Internal Medicine AB of Internal Medicine (1995)

  • Medical Oncology AB of Internal Medicine (1999)

Clinical Trials

Conditions Study Title
Larynx, Lip, Oral Cavity and Pharynx A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 With Tremelimumab or T
Lip, Oral Cavity and Pharynx NRG-HN002: Testing less intensive treatment for selected low-risk patients with oropharyngeal cancer
Other Endocrine System A091202: Efatutazone vs. Placebo in Pts With Previously Treated, Unresectable Myxoid Liposarcoma
Soft Tissue Individualized treatment for nasopharyngeal cancer based on the patient's DNA
Bladder S1011: Standard or Extended Pelvic Lymphadenectomy in Pts to have Surgery for Invasive Bladder Canc
Brain and Nervous System Germ Cell Tumor Pediatric CIRB study
Soft Tissue ARST1321 Non-Rhabdomyosarcoma Soft Tissue Sarcomas
Bones and Joints AEWS1221 Newly Diagnosed Metastatic Ewing Sarcoma
Bladder Novartis BGJ398: A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Stomach MK-3475 versus Standard Treatment in Subjects with Recurrent or Metastatic Head and Neck Cancer
Kidney S0931: Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Soft Tissue ALLIANCE A0911Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Soft Tissue RTOG 3501 (TRYHARD)
Prostate Medivation (PROSPER): Phase 3 Randomized, Double-Blind Study of Enzalutamide for Nonmetastatic CRPC
Lip, Oral Cavity and Pharynx E3311: Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy w/ or w/out Chemo
Bladder, Other Urinary ASG-22CE-13-2: A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of ASG-22CE
Prostate Bayer 16544: randomized phase IIa study of RAD-223 w/ abiraterone or enzalutamide
Prostate SWOG S1216: Phase III RCT for mCRPC pts comparing ADT and TAK700 with ADT and Bicalutamide
Lung Phase Ib study of MEDI4736 with Tremelimumab in Advanced NSCLC
Larynx, Lip, Oral Cavity and Pharynx RTOG 1216: RT With Cisplatin vs. Docetaxel and Cetuximab in Stage III-IV Squamous Cell H&N Cancer

Edit this profile

Contact Info

Hari Anant Deshpande, MD
Patient Care Locations
Yale Cancer CenterSmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 4th Floor

New Haven, CT 06511
View on map...
Smilow Cancer CareYale-New Haven Hospital Saint Raphael Campus
1450 Chapel Street, Ste Suite A

New Haven, CT 06511
View on map...
Mailing Address
PO Box 208028
333 Cedar Street,

New Haven, CT 06520-8028